Breakdown | |||||
TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.85M | 2.14M | 3.28M | 2.89M | 3.65M | 1.53M |
Gross Profit | |||||
1.37M | 2.06M | 3.21M | 2.62M | 3.19M | 1.09M |
EBIT | |||||
-6.22M | -3.97M | -3.97M | -6.29M | -6.67M | -5.43M |
EBITDA | |||||
-5.64M | -3.50M | -3.46M | -5.67M | -6.13M | -4.97M |
Net Income Common Stockholders | |||||
-3.82M | -3.01M | -3.23M | -5.41M | -6.10M | -4.93M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.09M | 4.54M | 4.17M | 6.67M | 11.64M | 16.38M |
Total Assets | |||||
8.24M | 6.95M | 6.35M | 9.22M | 14.72M | 18.97M |
Total Debt | |||||
521.92K | 542.23K | 239.37K | 332.26K | 357.96K | 476.31K |
Net Debt | |||||
-5.57M | -4.00M | -3.93M | -6.34M | -11.28M | -15.90M |
Total Liabilities | |||||
2.08M | 1.63M | 1.27M | 1.46M | 1.70M | 1.92M |
Stockholders Equity | |||||
6.17M | 5.32M | 5.08M | 7.76M | 13.02M | 17.04M |
Cash Flow | Free Cash Flow | ||||
-2.01M | -2.35M | -2.91M | -4.97M | -4.93M | -4.33M |
Operating Cash Flow | |||||
-2.01M | -2.32M | -2.81M | -4.80M | -4.52M | -3.89M |
Investing Cash Flow | |||||
-182.04K | -132.93K | -35.20K | -118.20K | -408.02K | -441.45K |
Financing Cash Flow | |||||
2.50M | 2.82M | 351.00K | -52.70K | 194.92K | 18.88M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $1.08B | 22.56 | 12.66% | 3.72% | 1.90% | -4.00% | |
65 Neutral | €1.70B | 49.73 | 3.35% | 2.15% | 4.28% | ― | |
64 Neutral | €1.21B | 16.02 | 7.21% | 6.21% | 6.54% | -0.58% | |
52 Neutral | $638.06M | 19.35 | 7.05% | ― | 75.76% | ― | |
51 Neutral | $840.50M | 25.13 | -0.01% | ― | 15.11% | ― | |
51 Neutral | $2.03B | -1.27 | -21.09% | 3.98% | 2.91% | -30.50% | |
45 Neutral | AU$10.10M | ― | -58.72% | ― | -26.94% | -4.08% |
Terragen Holdings Limited announced the resignation of its Chief Financial Officer and Company Secretary, Matthew Whyte, effective August 27, 2025, as he pursues other opportunities. The company is actively seeking his successor, and the transition is expected to impact its financial and administrative operations. The departure could influence Terragen’s strategic direction, given Whyte’s contributions to the company’s growth and development.
Terragen Holdings Limited has launched new probiotic products for ruminants, supported by extensive marketing efforts, and is conducting trials to assess their effectiveness in methane mitigation and animal health. The company is expanding its market reach with trials in Canada and collaborations for global market access, aiming to enhance its industry positioning and unlock new commercial opportunities.